Tumor Microcirculation

16:00      741.    Feasibility of Dynamic Susceptibility-Weighted Perfusion MRI at 3T Using a Standard Head Coil and 8-Channel Phased-Array Coil with and Without SENSE Reconstruction

Janine Marie Lupo¹, Michael C. Lee¹, Eric T. Han², Soonmee Cha¹, Susan M. Chang¹, Mitchel S. Berger¹,

Sarah J. Nelson¹

¹University of California, San Francisco, California, USA; ²Applied Science Lab-West, Menlo Park, California, USA
 

16:12      742.    A Novel Method of Model-Based Rigid Registration for Dynamic Contrast Enhanced MRI Studies.  - not available

Giovanni A. Buonaccorsi¹, Caleb Roberts¹, Sue Cheung¹, Yvon Watson¹, Geoff JM Parker¹

¹University of Manchester, Manchester, UK
 

16:24      743.    Deconvolution-Based Dynamic Contrast Enhanced MR Imaging of Breast Tumors for Perfusion Quantification: A Feasibility Study

Smitha Makkat¹, Steven Sourbron¹, Martine Dujardin¹, Peter Van Schuerbeek¹, Robert Luypaert¹, Tadeusz Stadnik¹

¹Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium
 

16:36      744.    Analysis of Metabolic Levels in Regions of Abnormal Perfusion in High-Grade Glioma Patients

Janine Marie Lupo¹, Soonmee Cha¹, Susan M. Chang¹, Mitchel S. Berger¹, Sarah J. Nelson¹

¹University of California, San Francisco, California, USA
 

16:48      745.    Dynamic Contrast Enhanced MRI (DCE-MRI) for Predicting Clinical Response to Bevacizumab and Chemotherapy in Previously Untreated Inflammatory Breast Cancer: A Comparison of Analytic Methods

Arpi Doshi¹, David Michael Thomasson¹, Reyes Maria Garcia-Eulate¹, Suparna Bonthala Wedam¹, Betty J. Wise¹, Sandeep N. Gupta², Jianhua Yao¹, Seth M. Steinberg¹, David J. Liewehr¹, Peter L. Choyke¹, Sandra M. Swain¹

¹National Institutes of Health, Bethesda, Maryland, USA; ²GE Healthcare Technologies, Baltimore, Maryland, USA
 

17:00      746.    Transfer Constant and Plasma Volume Fraction in Dynamic Contrast Enhanced Magnetic Resonance Imaging: Different Dependencies on Tumor Model, Size, and Antivascular Treatment

Thomas Nielsen¹, Ross J. Maxwell², Hans Stødkilde-Jørgensen¹, Leif Østergaard¹, Michael R. Horsman¹

¹Aarhus University Hospital, Aarhus, Denmark; ²Gray Cancer Institute, Northwood, UK
 

17:12      747.    Growth Factors and Integrins Associated with Contrast-Enhancing Regions of GBM  - not available

Samira Guccione¹, Yi-Shan Yang¹, Yen Lin Chia¹, Yingyung Wang¹, Michael Lim¹, Ron Homer¹, Griff Harsh¹,

Scott Atlas¹, Mark Bednarski¹

¹Stanford University, Stanford, California, USA
 

17:24      748.    Changes in the Transfer Constant of a Macromolecular MR Contrast Agent After Dexamethasone Administration in 9L Rat Cerebral Tumor  - not available

James Russell Ewing¹, Stephen Russell Brown¹, Jamie Russell Churchman¹, Swayamprava Russell Panda¹,

Ramesh Russell Paudyal¹, Joseph Russell Fenstermacher¹

¹Henry Ford Health Systems, Detroit, Michigan, USA
 

17:36      749.    Dynamic Contrast-Enhanced MRI for Quantifying VEGF-Enhanced Neovascularization in Tissue-Engineered Bladder Constructs

Hai-Ling Margaret Cheng^1,2, Jun Chen¹, Paul S. Babyn¹, Walid A. Farhat¹

¹The Hospital for Sick Children, Toronto, Ontario, Canada; ²University of Toronto, Toronto, Ontario, Canada
 

17:48      750.    Transcapillary Transport and Interstitial Fluid Pressure in Tumors; Monitoring by DCE-MRI Using Instantaneous and Slow Infusion.

Yaron Hassid¹, Raanan Margalit¹, Dalia Seger¹, Maya Dadiani¹, Hadassa Degani¹

¹Weizmann Institute Of Science, Rehovot, Israel